Latest news

Insights

Top 10 Trends Reshaping Pharmaceutical Sales

Executive Summary Pharmaceutical sales are undergoing one of the most significant transformations in decades. The traditional commercial model—built around face-to-face...
Clinical

MoonLake Reports Positive Phase 3 Results for Sonelokimab in Psoriatic Arthritis

MoonLake Immunotherapeutics has reported positive topline results from the phase 3 IZAR-1 trial evaluating its lead nanobody candidate, sonelokimab,...
Commercial

Jazz Pharmaceuticals to Acquire Actio for Up to $1.32 Billion to Add KCNT1 Epilepsy Therapy

Jazz Pharmaceuticals has agreed to acquire Actio Biosciences in a transaction valued at up to $1.32 billion, adding an...
Insights

Top 10 Technologies Accelerating Drug Discovery

Executive Summary Drug discovery is undergoing one of the most significant technological transformations in pharmaceutical history. Traditional discovery processes have...
Commercial

Actimed Reclaims Rights to Wasting Disease Drug; $126M Faraday Deal Dead

Actimed Therapeutics has regained worldwide rights to its muscle-wasting...
Manufacturing

Ensoma Restructures Operations to Focus on EN-374 for X-Linked Chronic Granulomatous Disease

Boston-based biotechnology company Ensoma has carried out another organizational...
Insights

What an Autonomous Clinical Trial Might Look Like by 2030

Executive Summary Clinical trials are undergoing one of the most significant transformations in pharmaceutical history. Advances in artificial intelligence (AI), digital...
Regulatory

Takeda’s Orzeyful Approved as First Orexin Agonist for Narcolepsy Type 1

The U.S. Food and Drug Administration (FDA) has approved Takeda’s oveporexton, which will be marketed under the brand name...
Commercial

The biggest pharmaceutical deal ever would be the “unlikely” AstraZeneca-BMS mega-merger

Word spread that two big pharma players, Bristol Myers Squibb and AstraZeneca, each valued at more than $130 billion,...
Commercial

Supernus and Indivior Agree to Create CNS-Focused Company in All-Stock Merger

Supernus Pharmaceuticals and Indivior Pharmaceuticals have agreed to combine...
Insights

From Data-Rich to Insight-Rich: Pharma’s Next Transformation

Executive Summary The pharmaceutical industry has become one of the...
Commercial

Hinge Health to Buy Out Cylinder Health in a Deal Worth Over $100M

Hinge Health has agreed to acquire digital gastrointestinal care startup Cylinder Health as the company expands its platform beyond...
Technology

Claryx Appears From Stealth to Deal with the $45B Hospital-Acquired Infections Issue

Healthcare-related infections remain a persistent challenge for hospitals, affecting roughly one in every 40 patients and placing a multibillion-dollar...
Clinical

Merck’s Tulisokibart Misses Phase 2 Endpoint in SSc-ILD but Meets Goals in HS Trial

Merck & Co. has reported mixed clinical results for tulisokibart, its investigational anti-TL1A monoclonal antibody, with a Phase 2...
Commercial

Novo Pens $5.2B Deal to Acquire Akero, Entering Liver Disease Space

The Agreement Novo Nordisk has agreed to acquire Akero Therapeutics...
Commercial

Opko & Entera Enter Partnership to Develop Obesity Pill

Opko Health and Entera Bio have formally announced their...

Popular

Most popular life news you must read today

View all articles

Commercial

Information Technology

Claryx Appears From Stealth to Deal with the $45B Hospital-Acquired Infections Issue

Healthcare-related infections remain a persistent challenge for hospitals, affecting roughly one in every 40...
Editorial Team -

J&J’s OTTAV Robotic Surgical System has received FDA market authorization in the U.S.

The U.S. Food and Drug Administration (FDA) granted Johnson & Johnson De Novo clearance...
Editorial Team -

Alnylam Inks $2B Agreement With Inceptive to Change sIRNA Design With AI Leader

Alnylam has entered into a partnership with the scientist instrumental in developing the technology...
Editorial Team -

Chugai and Gero Partner to Develop Antibodies for Age-Related Diseases Using AI

Chugai Pharmaceutical has entered into a research collaboration with Singapore-based Gero to develop antibody-based...
Editorial Team -

Regulatory

Clinical

MoonLake Reports Positive Phase 3 Results for Sonelokimab in Psoriatic Arthritis

MoonLake Immunotherapeutics has reported positive topline results from the...
Commercial

Jazz Pharmaceuticals to Acquire Actio for Up to $1.32 Billion to Add KCNT1 Epilepsy Therapy

Jazz Pharmaceuticals has agreed to acquire Actio Biosciences in...
Insights

Top 10 Technologies Accelerating Drug Discovery

Executive Summary Drug discovery is undergoing one of the most...
Regulatory

FDA Advisory Panel to Review Grail’s Galleri Multi-Cancer Blood Test in September

Grail said the U.S. Food and Drug Administration (FDA)...

Research & Development

Market Access

Manufacturing

Lilly and Profluent Sign Up to $2.25 Billion Collaboration to Develop AI-Designed Genetic Medicines

Eli Lilly has entered into a multi-program research collaboration...
Manufacturing

Avalyn Files for IPO Targeting Up to $209.7 Million to Advance Inhaled Lung Therapies

Avalyn Pharma, a Boston-based company focused on inhaled therapies...

Manufacturing & RegulatoryPOPULAR
Find Your Perfect Music Festival

Insights

Top 10 Trends Reshaping Pharmaceutical Sales

Executive Summary Pharmaceutical sales are undergoing one of the most...
Editorial Team -
Manufacturing

Novo Nordisk Sues Eli Lilly Over GLP-1 Drug Advertising Claims

Novo Nordisk has filed a lawsuit against Eli Lilly...
Editorial Team -